Update after 6-7 months - Amazing Comeback, please stick to your routine (look at previous post in my profile for ALL details)
    6/26/2025

    From the encyclopedia
    Minoxidil β†’

    Vasodilator used on the scalp and, at low doses, as a tablet

    Finasteride β†’

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    At a glance
    In this success story post, the primary subjects mentioned are
    πŸ’§ Minoxidil (topical) 2x daily 6-7 months
    πŸ’Š Finasteride (oral) 1mg 1x daily 6-7 months
    β€’ scalp massages 3-5 times a week
    the tone is πŸ˜€ positive with impressive results.

    Other terms

    The user experienced significant hair regrowth using topical minoxidil twice daily and 1mg oral finasteride once daily, along with scalp massages and a health supplement stack. Consistency with these treatments led to impressive results, boosting confidence and surprising family and friends.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Hair loss: a clinical update

      November 2019 in “Journal of Aesthetic Nursing”
      This article reviews the classifications and characteristics of androgenic alopecia and provides no new clinical results; it emphasizes the importance for aestheticians to understand current treatment evidence.

      research FEATURES

      1 citations , March 1997 in “Journal of the American Pharmaceutical Association”
      This guideline summary, endorsed by six Spanish pediatric societies, outlines consensus recommendations for managing childhood asthma, emphasizing diagnosis, maintenance treatment with low-dose inhaled corticosteroids, and patient education for effective control.

      research Interventions for central serous chorioretinopathy: a network meta-analysis

      4 citations , June 2025 in “Cochrane Database of Systematic Reviews”
      This Cochrane review found no clear superiority among treatments for central serous chorioretinopathy, with low-dose photodynamic therapy, supplements, and eplerenone showing slightly higher probabilities of improving visual acuity, but evidence remains uncertain due to biases and small study sizes.